Frankfurt - Delayed Quote EUR

OrthoPediatrics Corp. (2X7.F)

Compare
22.80 +0.40 (+1.79%)
As of 1:42:36 PM GMT+1. Market Open.
Loading Chart for 2X7.F
DELL
  • Previous Close 22.40
  • Open 22.60
  • Bid 23.00 x --
  • Ask 23.40 x --
  • Day's Range 22.60 - 22.80
  • 52 Week Range 20.60 - 32.40
  • Volume 1
  • Avg. Volume 3
  • Market Cap (intraday) 560.547M
  • Beta (5Y Monthly) 1.16
  • PE Ratio (TTM) --
  • EPS (TTM) -1.19
  • Earnings Date Mar 4, 2025 - Mar 10, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

www.orthopediatrics.com

247

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 2X7.F

View More

Performance Overview: 2X7.F

Trailing total returns as of 1/7/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

2X7.F
4.59%
S&P 500
0.59%

1-Year Return

2X7.F
19.72%
S&P 500
26.50%

3-Year Return

2X7.F
51.90%
S&P 500
26.53%

5-Year Return

2X7.F
46.22%
S&P 500
83.03%

Compare To: 2X7.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 2X7.F

View More

Valuation Measures

As of 1/6/2025
  • Market Cap

    558.60M

  • Enterprise Value

    555.31M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.80

  • Price/Book (mrq)

    1.51

  • Enterprise Value/Revenue

    3.02

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -15.00%

  • Return on Assets (ttm)

    -3.94%

  • Return on Equity (ttm)

    -7.63%

  • Revenue (ttm)

    189.67M

  • Net Income Avi to Common (ttm)

    -28.44M

  • Diluted EPS (ttm)

    -1.19

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    76.06M

  • Total Debt/Equity (mrq)

    21.36%

  • Levered Free Cash Flow (ttm)

    -50.25M

Research Analysis: 2X7.F

View More

People Also Watch